Monoclonal thyroglobulin autoantibodies: variable region analysis and epitope recognition. 1995

L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
Endocrine Immunology Unit, University of Wales College of Medicine, Cardiff, United Kingdom.

A panel of human monoclonal thyroglobulin (Tg) autoantibodies (TgAAb) has been used to analyze autoantigenic determinants on human Tg and to investigate the relationship between variable (V) region gene sequences and epitope specificity. Two monoclonal TgAAb bound to the same (or closely related) epitope on Tg, and these were defined as type I TgAAb. Three other monoclonals bound to a different site and were defined as type II TgAAb. Inhibition studies with mixtures of type I and type II monoclonal TgAAb (Fab)2 preparations indicated that a mixture of the (Fab)2s almost completely inhibited (> 75%) labeled Tg binding to intact TgAAb in the sera of apparently healthy blood donors and patients with autoimmune thyroid disease (AITD). Type I TgAAb predominated in apparently healthy blood donors' sera, whereas type II TgAAb predominated in AITD sera. Analysis of V region gene sequences of the TgAAb indicated that a range of light chain and heavy chain genes from different gene families was used. Furthermore, the same germline genes that are used by TgAAb are also well represented in the genes coding for other self- and nonself-reactive antibodies. No homology in terms of light chain and heavy chain gene families, germline gene usage, or complementarity determining region sequences was observed in TgAAb directed to the same or closely related epitopes. Our studies show that TgAAb are directed to two major conformational epitopes on the Tg molecule and that the proportion of TgAAb directed to these epitopes in apparently healthy blood donors and that in patients with AITD appear to be different. TgAAb derived from different germline genes and with different complementarity determining region sequences can display similar epitope specificity, and this indicates that AAb directed to the same or a closely related epitope show considerable heterogeneity at the molecular level.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
November 1992, Journal of immunology (Baltimore, Md. : 1950),
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
January 2003, The Journal of clinical endocrinology and metabolism,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
July 2007, Immunology,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
February 1992, European journal of immunology,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
January 1991, Autoimmunity,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
October 2004, The Journal of clinical endocrinology and metabolism,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
October 1988, Clinical and experimental immunology,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
March 1990, Journal of clinical & laboratory immunology,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
January 1991, Autoimmunity,
L Prentice, and Y Kiso, and N Fukuma, and M Horimoto, and V Petersen, and F Grennan, and C Pegg, and J Furmaniak, and B Rees Smith
February 1993, American journal of veterinary research,
Copied contents to your clipboard!